Saltar al contenido
Merck

Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature.

Reviews of infectious diseases (1986-05-01)
P G Spitzer, S M Hammer, A W Karchmer
RESUMEN

A 55-year-old female recipient of an orthotopic liver transplant, who was receiving azathioprine, prednisone and cyclosporin, developed bacteremia due to Listeria monocytogenes. Because of a penicillin allergy, the patient was treated primarIly with trimethoprim-sulfamethoxazole, to which she responded well. The prior literature on use of trimethoprim-sulfamethoxazole in listeria infections is reviewed, and future recommendations are considered. On the basis of the experience described in this case report as well as a review of the literature, trimethoprim-sulfamethoxazole appears to be an effective treatment of listeria infections.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
Sulfamethoxazole
USP
Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard
Supelco
Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Sulfamethoxazole, VETRANAL®, analytical standard
Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard
Supelco
Sulfamethoxazole, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland